Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Autoimmune
Cancer
Cardiovascular
COVID-19
Health Topics
Infectious
Trichomonas
Medline signs on as Visby distributor
By
LabPulse.com staff writers
A handheld PCR test with a CLIA waiver, the all-in-one unit can provide diagnostic test results in under 30 minutes for sexually transmitted infections in women, the firms said.
August 1, 2022
BD launches BD COR MX/PX infectious disease platform
By
LabPulse.com staff writers
BD COR MX/PX integrates and automates the complete molecular laboratory workflow, from sample processing to diagnostic test results, for large, high-throughput labs, the company said.
May 12, 2022
Abbott’s STI test gets FDA nod
By
LabPulse.com staff writers
The Alinity m STI test uses polymerase chain reaction (PCR) to detect Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis, and Mycoplasma genitalium. The test requires one swab sample, or a urine sample collected in a healthcare setting, and it runs on Abbott's Alinity m molecular laboratory instrument.
May 3, 2022
DCN Dx acquires Biomed Diagnostics
By
LabPulse.com staff writers
The purchase expands DCN Dx's reach into the point-of-use testing and sampling market by adding a number of tests to its portfolio, including InPouch TV for detection of Trichomonas vaginalis, Transport Media (VTM) for SARS-CoV-2 sample transport, and InTray VS COLOREX for testing for methicillin-resistant Staphylococcus aureus (MRSA).
April 24, 2022
Rheonix gets FDA nod for STI test, workstation
By
LabPulse.com staff writers
The Encompass MDx workstation enables scalable, multiplexed sample-to-answer detection, simplifying laboratory workflows.
January 11, 2022
BD Cor system features MX instrument for infectious diseases
By
LabPulse.com staff writers
The new instrument and its first test for sexually transmitted infections have received the CE Mark for IVD directive 98/79/EC.
December 16, 2021
Page 1 of 1